14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 4552.T
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

JCR Pharmaceuticals Co.,Ltd. stock upgraded to Hold/Accumulate.
(Updated on Jun 25, 2024)

Hold candidate since Jun 25, 2024 PDF

The JCR Pharmaceuticals Co.,Ltd. stock price gained 2.71% on the last trading day (Tuesday, 25th Jun 2024), rising from JP¥590.00 to JP¥606.00. During the last trading day the stock fluctuated 2.19% from a day low at JP¥594.00 to a day high of JP¥607.00. The price has risen in 6 of the last 10 days and is up by 5.03% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 88 thousand more shares were traded than the day before. In total, 520 thousand shares were bought and sold for approximately JP¥315.00 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at JP¥612.49 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -36.98% during the next 3 months and, with a 90% probability hold a price between JP¥268.37 and JP¥385.99 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

4552.T Signals & Forecast

The JCR Pharmaceuticals Co.,Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at JP¥589.14 and JP¥604.57. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, May 29, 2024, and so far it has risen 13.06%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for JCR Pharmaceuticals Co.,Ltd. stock

JCR Pharmaceuticals Co.,Ltd. finds support from accumulated volume at JP¥586.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved JP¥13.00 between high and low, or 2.19%. For the last week, the stock has had daily average volatility of 2.37%.

Our recommended stop-loss: JP¥584.43 (-3.56%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 49 days ago.)

Trading Expectations (4552.T) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect JCR Pharmaceuticals Co.,Ltd. to open at JP¥602.33, and during the day (based on 14 day Average True Range), to move between JP¥587.98 and JP¥624.02, which gives a possible trading interval of +/-JP¥18.02 (+/-2.97%) up or down from last closing price. If JCR Pharmaceuticals Co.,Ltd. takes out the full calculated possible swing range there will be an estimated 5.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at JP¥586.00 (3.30%) than the resistance at JP¥628.00 (3.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is JCR Pharmaceuticals Co.,Ltd. stock A Buy?

JCR Pharmaceuticals Co.,Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for JCR Pharmaceuticals Co.,Ltd. of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
JP¥602.33 ( 0.605%) JP¥606.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 4552.T

Fibonacci Support & Resistance Levels

Level Price
R3 615.33 1.54%
R2 610.37 0.721%
R1 607.30 0.214%
Price 606.00
S1 597.37 -1.42%
S2 594.30 -1.93%
S3 589.33 -2.75%

Accumulated Volume Support & Resistance Levels

Level Price
R3 648.00 6.93%
R2 640.00 5.61%
R1 628.00 3.63%
Price 606.00
S1 586.00 -3.30%
S2 577.00 -4.79%
S3 575.00 -5.12%

4552 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 27, 2024 Sep 27, 2024 Sep 27, 2024 JP¥0 0%
2 Mar 28, 2024 Mar 28, 2024 Jun 27, 2024 JP¥10.00 1.65%
3 Sep 28, 2023 Sep 28, 2023 Dec 08, 2023 JP¥10.00 0.85%
4 Mar 30, 2023 Mar 30, 2023 Mar 30, 2023 JP¥10.00 0.653%
5 Sep 29, 2022 Sep 29, 2022 Sep 29, 2022 JP¥10.00 0.457%

FAQ

What is the symbol for JCR Pharmaceuticals Co.,Ltd. Stock and on which exchange is it traded?
The symbol for JCR Pharmaceuticals Co.,Ltd. is 4552.T and it is traded on the TYO (Tokyo Stock Exchange).

Should I buy or sell JCR Pharmaceuticals Co.,Ltd. Stock?
JCR Pharmaceuticals Co.,Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy JCR Pharmaceuticals Co.,Ltd. Stock?
JCR Pharmaceuticals Co.,Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy JCR Pharmaceuticals Co.,Ltd. Stock.

What's the current price of JCR Pharmaceuticals Co.,Ltd. Stock?
As of the end of day on the Jun 25, 2024, the price of an JCR Pharmaceuticals Co.,Ltd. (4552.T) share was JP¥606.00.

What is the 52-week high and low for JCR Pharmaceuticals Co.,Ltd. Stock?
The 52-week high for JCR Pharmaceuticals Co.,Ltd. Stock is JP¥1,567.00 and the 52-week low is JP¥522.00.

What is the market capitalization of JCR Pharmaceuticals Co.,Ltd. Stock?
As of the Jun 25, 2024, the market capitalization of JCR Pharmaceuticals Co.,Ltd. is 73.634B.

When is the next earnings date for JCR Pharmaceuticals Co.,Ltd.?
The upcoming earnings date for JCR Pharmaceuticals Co.,Ltd. is Jul 24, 2024.
Click to get the best stock tips daily for free!

About JCR Pharmaceuticals Co.,Ltd.

JCR Pharmaceuticals Co.Ltd. JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for t... 4552.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT